Overview
Pemoline in the Treatment of Stimulant Dependence - 5
Status:
Withdrawn
Withdrawn
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
National Institute on Drug Abuse (NIDA)Treatments:
Central Nervous System Stimulants
Pemoline
Criteria
Inclusion Criteria:M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
study and sign informed consent.
Exclusion Criteria:
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or
nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute
hepatitis. Other medical condtions that deem participation to be unsafe.